Processa Pharmaceuticals, Inc.
PCSA· Nasdaq
PCSAProcessa Pharmaceuticals, Inc.
Filed May 15, 2020 · 10-Q · 45 days after period end · 0001493152-20-009002
| Metric | Q1 2020 | Q1 2019 | Q1 2018 | Q1 2017 |
|---|---|---|---|---|
| Net Income | -$874.34K | -$750.83K | -$1.10M | -$75.63K |
| EPS Diluted | -$0.16 | -$0.14 | -$0.03 | -$0.01 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Processa Pharmaceuticals, Inc. · CIK 1533743 · Engraved from SEC EDGAR
ended Mar 31, 2020 · filed May 15, 2020 · 45 d after period end
